Related Experiment Video
Updated: Jun 12, 2026

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
Published on: April 1, 2019
Transcobalamin II receptor polymorphisms are associated with increased risk for neural tube defects
F Pangilinan1, A Mitchell, J VanderMeer
1Molecular Pathogenesis Section, Genome Technology Branch, National Human Genome Research Institute, 50 South Drive, Bethesda, MD 20892-8004, USA.
Genetic variants in the transcobalamin II receptor (TCblR) gene are linked to neural tube defects (NTDs). These TCblR variants may increase NTD risk by affecting vitamin B12 metabolism.
Area of Science:
- Genetics
- Human Health
- Biochemistry
Background:
- Low cobalamin (vitamin B12) levels in pregnant women increase the risk of neural tube defects (NTDs) in offspring.
- The transcobalamin II receptor (TCblR) is crucial for cellular uptake of cobalamin.
Purpose of the Study:
- To investigate inherited variants in the TCblR gene as potential risk factors for NTDs.
- To evaluate the association between common TCblR variations and NTD occurrence.
Main Methods:
- Employed case-control and family-based association tests to screen for TCblR genetic variations.
- Utilized a large Irish cohort and confirmatory NTD trios for robust analysis.
Main Results:
- Identified two linked TCblR variants, rs2336573 (G220R) and rs9426, significantly associated with NTDs in a recessive model (p(corr)=0.0080 and p(corr)=0.0279, respectively).
- Family-based tests confirmed the association, showing a strong risk ratio for these variants.
- Described a copy number variant and two novel exonic insertion-deletion polymorphisms in the TCblR region.
Conclusions:
- TCblR variants rs2336573 (G220R) and rs9426 are significant risk factors for NTDs in the Irish population.
- The high penetrance and low frequency of the homozygous risk genotype in controls suggest a potent, albeit rare, NTD risk factor.
- TCblR gene variation likely influences cobalamin metabolism and plays a role in NTD susceptibility.
More Related Videos
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
09:37Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...